Cybin Inc Net Income per Employee (CYBN), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Cybin Inc   (NYSEAMER: CYBN)
 

Cybin Inc Net Income per Employee

CYBN's Quarterly Results, Trends, Rankings, Statistics
Cybin Inc recorded a cumulative net loss of $-87 million during 12 month ending in the fourth quarter 2025.
The Healthcare sector has seen Cybin Inc achieved the highest income per employee. While income per employee remained unchanged compared to the previous quarter at no. .


What is Income per Employee Ratio?






CYBN Net Income per Employee (Mar 31 2025)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Mar 31 2024)
IV. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -2,888,765 -1,993,643 -1,993,643 -1,993,643 -1,993,643
CYBN's Total Ranking # # # # # 4419
Seq. Net Income Change - - - - -


CYBN Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Net Income per Employee Statistics
High Average Low
$ -1,993,643 $ -1,993,643 $ -1,993,643
(Mar 31 2024)  







Companies with similar Income per Employee for 12 month ending Mar 31 2025, within Healthcare Sector Income per Employee Income 12 month ending Mar 31 2025Number of Employees Mar 31 2025


Date modified: 2026-07-07T10:16:31+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.